SBRA vs. URA

Last updated Jun 20, 2026

SBRA (Sabra Health Care REIT, Inc.) is a stock, while URA (Global X Uranium ETF) is Uranium fund tracking the Solactive Global Uranium & Nuclear Components Total Return Index. Over the past 10 years, SBRA returned 6.89%/yr vs 16.35%/yr for URA. At a 0.22 correlation, their price movements are largely independent.

Performance

SBRA vs. URA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sabra Health Care REIT, Inc. (SBRA) and Global X Uranium ETF (URA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SBRA achieves a -1.50% return, which is significantly lower than URA's 11.82% return. Over the past 10 years, SBRA has underperformed URA with an annualized return of 6.89%, while URA has yielded a comparatively higher 16.35% annualized return.

SBRA

• 1D: 0.39%
• 1M: -12.55%
• YTD: -1.50%
• 6M: -0.18%
• 1Y: 5.62%
• 3Y*: 23.82%
• 5Y*: 9.18%
• 10Y*: 6.89%

URA

• 1D: 1.44%
• 1M: -2.41%
• YTD: 11.82%
• 6M: 9.09%
• 1Y: 36.15%
• 3Y*: 34.26%
• 5Y*: 22.77%
• 10Y*: 16.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SBRA vs. URA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SBRA Sabra Health Care REIT, Inc.	-1.50%	17.02%	31.23%	26.26%	0.38%	-16.16%	-11.33%	41.14%	-3.73%	-16.83%
URA Global X Uranium ETF	11.82%	67.18%	-0.58%	46.25%	-11.32%	57.57%	41.33%	-3.54%	-22.11%	19.36%

Correlation

The correlation between SBRA and URA is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.18
Correlation (All Time) Calculated using the full available price history since Nov 5, 2010	0.22

The correlation between SBRA and URA shifts across timeframes, from -0.12 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Return for Risk

SBRA vs. URA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBRA

SBRA Risk / Return Rank: 48
SBRA Sharpe Ratio Rank: 52
SBRA Sortino Ratio Rank: 44
SBRA Omega Ratio Rank: 42
SBRA Calmar Ratio Rank: 50
SBRA Martin Ratio Rank: 54

URA

URA Risk / Return Rank: 21
URA Sharpe Ratio Rank: 19
URA Sortino Ratio Rank: 22
URA Omega Ratio Rank: 21
URA Calmar Ratio Rank: 23
URA Martin Ratio Rank: 20

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBRA vs. URA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sabra Health Care REIT, Inc. (SBRA) and Global X Uranium ETF (URA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SBRA	URA	Difference
Sharpe ratio: Return per unit of total volatility	0.26	0.64	-0.38
Sortino ratio: Return per unit of downside risk	0.52	1.21	-0.69
Omega ratio: Gain probability vs. loss probability	1.06	1.14	-0.08
Calmar ratio: Return relative to maximum drawdown	0.34	1.04	-0.70
Martin ratio: Return relative to average drawdown	1.10	2.26	-1.17

SBRA vs. URA - Sharpe Ratio Comparison

The current SBRA Sharpe Ratio is 0.26, which is lower than the URA Sharpe Ratio of 0.64. The chart below compares the historical Sharpe Ratios of SBRA and URA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SBRA vs. URA - Drawdown Comparison

The maximum SBRA drawdown since its inception was -99.49%, which is greater than URA's maximum drawdown of -93.54%. Use the drawdown chart below to compare losses from any high point for SBRA and URA.

Drawdown Indicators

	SBRA	URA	Difference
Max Drawdown Largest peak-to-trough decline	-99.49%	-93.54%	-5.95%
Max Drawdown (1Y) Largest decline over 1 year	-16.10%	-31.48%	+15.38%
Max Drawdown (3Y) Largest decline over 3 years	-16.78%	-37.81%	+21.03%
Max Drawdown (5Y) Largest decline over 5 years	-36.79%	-37.90%	+1.11%
Max Drawdown (10Y) Largest decline over 10 years	-74.93%	-61.45%	-13.48%
Current Drawdown Current decline from peak	-13.96%	-45.78%	+31.82%
Average Drawdown Average peak-to-trough decline	-37.68%	-74.91%	+37.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.97%	14.41%	-9.44%

Volatility

SBRA vs. URA - Volatility Comparison

The current volatility for Sabra Health Care REIT, Inc. (SBRA) is 9.65%, while Global X Uranium ETF (URA) has a volatility of 17.77%. This indicates that SBRA experiences smaller price fluctuations and is considered to be less risky than URA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SBRA	URA	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.65%	17.77%	-8.12%
Volatility (6M) Calculated over the trailing 6-month period	16.23%	39.65%	-23.42%
Volatility (1Y) Calculated over the trailing 1-year period	20.95%	51.29%	-30.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.99%	43.88%	-16.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	36.46%	37.94%	-1.48%

Dividends

SBRA vs. URA - Dividend Comparison

SBRA's dividend yield for the trailing twelve months is around 6.62%, more than URA's 4.36% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SBRA Sabra Health Care REIT, Inc.	6.62%	6.34%	6.93%	8.41%	9.65%	8.86%	7.77%	8.43%	10.92%	9.22%	6.84%	7.91%
URA Global X Uranium ETF	4.36%	4.88%	2.86%	6.07%	0.76%	5.84%	1.69%	1.66%	0.44%	2.03%	7.28%	1.96%

Frequently Asked Questions

Can I hold both SBRA and URA in my portfolio?

SBRA and URA have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SBRA or URA?

URA has higher volatility (17.77%) compared to SBRA (9.65%). In terms of maximum drawdown, SBRA dropped -99.49% vs URA's -93.54%.

Which has better risk-adjusted returns?

URA currently has the higher Sharpe Ratio (0.64 vs 0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.